F. Mayer
Impact in
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
- Obstetrics and Gynecology top 10%
- Endometrial and Cervical Cancer Treatments
Papers in
- Oncology 11
- Cancer Treatment and Pharmacology 7
- Cancer Diagnosis and Treatment 2
- HER2/EGFR in Cancer Research 2
-
- Ovarian cancer diagnosis and treatment 10
- Co-authors
- Hugues Bourgeois (6 shared papers)B. Weber (5 shared papers)Éric Pujade-Lauraine (5 shared papers)Hubert Orfeuvre (4 shared papers)M. Combe (4 shared papers)D. Paraïso (4 shared papers)D. Lepillé (3 shared papers)Bernard Leduc (3 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Annals of Oncology (3 papers)Anti-Cancer Drugs (3 papers)European Journal of Cancer (2 papers)Gynecologic Oncology (2 papers)
- Partner nations
- FranceGermanySwitzerland
In The Last Decade
F. Mayer
31 papers receiving 367 citations
Peers
Comparison fields: 5 of 52
- Reproductive Medicine 166
- Obstetrics and Gynecology 43
- Surgery 146
- Oncology 81
- Pathology and Forensic Medicine 46
Countries citing papers authored by F. Mayer
This map shows the geographic impact of F. Mayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Mayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Mayer more than expected).
Fields of papers citing papers by F. Mayer
This network shows the impact of papers produced by F. Mayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Mayer. The network helps show where F. Mayer may publish in the future.
Co-authors
The 25 scholars most cited alongside F. Mayer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 89 | |
| 2 | 2007 | 72 | |
| 3 | 2012 | 32 | |
| 4 | 2000 | 21 | |
| 5 | 1999 | 20 | |
| 6 | Pegylated liposomal doxorubicin and carboplatin in late-relapsing ovarian cancer: a GINECO group phase II trial. | 2009 | 19 |
| 7 | 2009 | 14 | |
| 8 | 2006 | 14 | |
| 9 | 2004 | 12 | |
| 10 | 2010 | 11 | |
| 11 | 2005 | 11 | |
| 12 | 1994 | 11 | |
| 13 | 2007 | 6 | |
| 14 | 2009 | 6 | |
| 15 | 1986 | 6 | |
| 16 | 1993 | 5 | |
| 17 | 2010 | 5 | |
| 18 | 2016 | 4 | |
| 19 | 2010 | 4 | |
| 20 | [Course of blood creatinine during repeated injections of cisplatin. Influence of drug combinations]. | 1991 | 4 |
About F. Mayer
F. Mayer is a scholar working on Oncology, Reproductive Medicine, Surgery, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 34 papers that have together received 388 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (10 papers), Cancer Treatment and Pharmacology (7 papers), Intraperitoneal and Appendiceal Malignancies (5 papers), Testicular diseases and treatments (3 papers), Lung Cancer Treatments and Mutations (3 papers), Sarcoma Diagnosis and Treatment (2 papers), Cancer Diagnosis and Treatment (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Reproductive Medicine (166 citations), Obstetrics and Gynecology (43 citations), Surgery (146 citations), Oncology (81 citations) and Pathology and Forensic Medicine (46 citations). F. Mayer has collaborated with scholars based in France, Germany and Switzerland. Frequent co-authors include Hugues Bourgeois, B. Weber, Éric Pujade-Lauraine, Hubert Orfeuvre, M. Combe, D. Paraïso, D. Lepillé, Bernard Leduc, Jean-Marc Ferrero and Pierre Kerbrat. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Anti-Cancer Drugs, European Journal of Cancer and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.